Sternberg, C., Saad, F., Graff, J., Peer, A., Vaishampayan, U., Leung, E., . . . Hussain, M. (2020). A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer. Annals of Oncology, 31(2), 257. https://doi.org/10.1016/j.annonc.2019.10.025
Chicago Style (17th ed.) CitationSternberg, C.N, et al. "A Randomised Phase II Trial of Three Dosing Regimens of Radium-223 in Patients with Bone Metastatic Castration-resistant Prostate Cancer." Annals of Oncology 31, no. 2 (2020): 257. https://doi.org/10.1016/j.annonc.2019.10.025.
MLA (9th ed.) CitationSternberg, C.N, et al. "A Randomised Phase II Trial of Three Dosing Regimens of Radium-223 in Patients with Bone Metastatic Castration-resistant Prostate Cancer." Annals of Oncology, vol. 31, no. 2, 2020, p. 257, https://doi.org/10.1016/j.annonc.2019.10.025.